Arthur A Levin insider trades: Stoke Therapeutics (STOK) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Arthur reports to the SEC
Open-market buys and sales
36 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | STOK | ↓ Sell | 605 | $36.80 | $22K | Direct | Mar 17, 2026 (4d) |
| Jan 21, 2026 | RNA | ↓ Sell10b5-1 | 1,758 | $72.45 | $127K | Direct | Jan 23, 2026 (2d) |
| Aug 6, 2025 | RNA | ↓ Sell | 107,500 | $47.62 | $5.1M | Direct | Aug 8, 2025 (2d) |
| Jan 21, 2025 | RNA | ↓ Sell10b5-1 | 1,872 | $28.60 | $54K | Direct | Jan 23, 2025 (2d) |
| Nov 19, 2024 | RNA | ↓ Sell | 3,323 | $42.12 | $140K | Direct | Nov 20, 2024 (1d) |
| Oct 21, 2024 | RNA | ↓ Sell | 5,000 | $46.63 | $233K | Direct | Oct 23, 2024 (2d) |
| Sep 19, 2024 | RNA | ↓ Sell | 5,000 | $45.73 | $229K | Direct | Sep 20, 2024 (1d) |
| Aug 19, 2024 | RNA | ↓ Sell | 5,000 | $45.19 | $226K | Direct | Aug 21, 2024 (2d) |
| Jul 19, 2024 | RNA | ↓ Sell | 5,000 | $45.01 | $225K | Direct | Jul 23, 2024 (4d) |
| Jun 20, 2024 | RNA | ↓ Sell | 5,000 | $37.59 | $188K | Direct | Jun 21, 2024 (1d) |
| Jun 13, 2024 | RNA | ↓ Sell | 100,000 | $38.07 | $3.8M | By family trust | Jun 14, 2024 (1d) |
| May 20, 2024 | RNA | ↓ Sell | 5,000 | $29.90 | $149K | Direct | May 21, 2024 (1d) |
| Apr 19, 2024 | RNA | ↓ Sell | 5,000 | $22.82 | $114K | Direct | Apr 22, 2024 (3d) |
| Apr 3, 2024 | RNA | ↓ Sell | 20,000 | $27.11 | $542K | By family trust | Apr 3, 2024 (0d) |
| Mar 19, 2024 | RNA | ↓ Sell | 5,000 | $23.97 | $120K | Direct | Mar 21, 2024 (2d) |
| Mar 12, 2024 | RNA | ↓ Sell | 27,641 | $22.03 | $609K | Direct | Mar 12, 2024 (0d) |
| Jan 22, 2024 | RNA | ↓ Sell10b5-1 | 1,859 | $10.13 | $19K | Direct | Jan 23, 2024 (1d) |
| Mar 15, 2023 | RNA | ↓ Sell | 100 | $22.01 | $2K | Direct | Mar 17, 2023 (2d) |
| Feb 14, 2023 | RNA | ↓ Sell | 10,000 | $23.66 | $237K | Direct | Feb 15, 2023 (1d) |
| Jan 12, 2023 | RNA | ↓ Sell | 10,000 | $22.00 | $220K | Direct | Jan 17, 2023 (5d) |
| Dec 29, 2022 | RNA | ↓ Sell | 40,000 | $22.01 | $881K | Direct | Jan 3, 2023 (5d) |
| Aug 16, 2022 | RNA | ↓ Sell | 80,000 | $22.10 | $1.8M | Direct | Aug 31, 2022 (15d) |
| Nov 18, 2021 | RNA | ↓ Sell | 25,000 | $27.89 | $697K | Direct | Nov 22, 2021 (4d) |
| Jun 25, 2021 | RNA | ↓ Sell | 20,200 | $28.12 | $568K | Direct | Jun 28, 2021 (3d) |
| Jun 17, 2021 | RNA | ↓ Sell | 200 | $27.75 | $6K | Direct | Jun 22, 2021 (5d) |
| Jun 15, 2021 | RNA | ↓ Sell | 37,022 | $25.98 | $962K | By charitable remainder trust | Jun 16, 2021 (1d) |
| Mar 16, 2021 | RNA | ↓ Sell | 4,600 | $27.87 | $128K | Direct | Mar 18, 2021 (2d) |
| Mar 1, 2021 | STOK | ↓ Sell | 12,500 | $60.79 | $760K | Direct | Mar 3, 2021 (2d) |
| Apr 25, 2007 | ISIS | ↓ Sell10b5-1 | 6,000 | $10.11 | $61K | Direct | Apr 27, 2007 (2d) |
| Nov 13, 2006 | ISIS | ↓ Sell10b5-1 | 50,000 | $12.07 | $603K | Direct | Nov 13, 2006 (0d) |
| Oct 19, 2006 | ISIS | ↓ Sell10b5-1 | 12,424 | $8.98 | $112K | Direct | Oct 23, 2006 (4d) |
| Oct 6, 2006 | ISIS | ↓ Sell10b5-1 | 9,493 | $7.97 | $76K | Direct | Oct 10, 2006 (4d) |
| Oct 6, 2006 | ISIS | ↓ Sell10b5-1 | 507 | $7.96 | $4K | Direct | Oct 10, 2006 (4d) |
| Mar 21, 2006 | ISIS | ↓ Sell10b5-1 | 10,000 | $9.04 | $90K | Direct | Mar 22, 2006 (1d) |
| Feb 17, 2006 | ISIS | ↓ Sell10b5-1 | 7,770 | $8.03 | $62K | Direct | Feb 22, 2006 (5d) |
| Feb 16, 2006 | ISIS | ↓ Sell10b5-1 | 3,000 | $7.95 | $24K | Direct | Feb 17, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other STOK insiders
Open-market trades in the last 12 months
About Arthur A Levin's insider trades
Arthur A Levin is an insider at Stoke Therapeutics (STOK). Since Feb 16, 2006, Arthur has reported no open-market purchases and 36 sales worth $19.2M on SEC Form 4. In the last 12 months: 2 sales ($150K).
11 sales (6% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (32 filings), grants and awards (15 filings), gifts (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every STOK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.